Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
Provider: New Constructs, LLC
Provider: MacroRisk Analytics/EconomicInvestor
Provider: ValuEngine, Inc.

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Celldex Therapeutics Inc Announces $75,000,000 Proposed Public Offering of Common Stock

Monday, 4 Feb 2013 04:01pm EST 

Celldex Therapeutics Inc announced that it is offering $75,000,000 of its common stock in a proposed underwritten public offering. All of the shares in the offering will be sold by Celldex. The offering is subject to market conditions, and there can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering. The shares will be issued pursuant to a prospectus supplement filed as part of a shelf registration statement previously filed with the Securities and Exchange Commission (SEC) on Form S-3. Jefferies & Company, Inc. and Leerink Swann LLC are acting as the joint book-running managers and underwriters for the proposed offering. 

Company Quote

-0.26 -1.78%
4:00pm EDT